Forbes – Google is not the only technology company that extended its work from home policy. Several other companies recently have made announcements about remote work.
The Hill – Children seem to be less susceptible than older people to the most serious symptoms of the coronavirus and the disease it causes, COVID-19, though they are no less likely to contract the virus itself.
POLITICO – The Trump administration is narrowing down candidates for a new post to coordinate the development of Covid-19 therapies and vaccines, with a former National Institutes of Health director emerging as a leading choice.
Bloomberg Law – The FDA and NIH haven’t been able to recruit top scientists under an authority provided in the 21st Century Cures law because they’re still waiting for guidance on how many people they can hire.
Nextgov – Genetic sequencing tools and CRISPR-based technology help scientists thoroughly probe the most micro happenings inside of cells in multi-dimensional ways—and researchers at Sandia National Laboratory are now putting them to use against COVID-19.
The Conversation – Now, two months after implementing some form of physical distancing, European governments are planning to reopen their economies.
Texas Public Radio – While the technology may be more precise than human memory, it raises fears about greater surveillance at work — and whether employers would relinquish that power after the health crisis subsides.
STAT – The federal government on Saturday announced a plan to distribute remdesivir following nearly a week of chaos and confusion surrounding which hospitals and which states would receive the medication, and how they were chosen.
STAT – At the heart of the decision about when to end the trial was a process that was — as is often in the case in clinical trials — by turns secretive and bureaucratic.